Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Delamanid

A new-generation antituberculosis drug, authorised in Europe in 2014 for multidrug-resistant pulmonary tuberculosis, always in combination with other drugs. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It blocks the production of methoxy- and keto-mycolic acids, long waxy molecules that form the tough cell wall of the tuberculosis bacillus.

DelamanidGo to the active ingredient →
DelamanidActive ingredientDelamanidCat. No. P-D037-001CAS 681492-22-8
Delamanid-d4Isotopically labelledDelamanid-d4Cat. No. P-D037-003CAS 2747917-54-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.